SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Medical device-based neuromodulation for motor symptoms in Parkinson's disease: a systematic review and meta-analysis.

Front Neurol · 2026-02-12

DOI: 10.3389/fneur.2026.1731885PMID: 41766996

Open accessSystematic Review; systematic-review; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

ObjectiveTo synthesize randomized clinical trial (RCT) evidence comparing the efficacy of medical device-based neuromodulation (MDBN) techniques for improving motor symptoms in Parkinson's disease (PD).BackgroundDevice-based neuromodulation therapies, including deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS), are used to target PD motor symptoms, but reported effect sizes vary substantially across trials.MethodsA systematic review was conducted in accordance with PRISMA guidelines. RCTs evaluating MDBN for PD motor function, measured by the Unified Parkinson's Disease Rating Scale Part III (UPDRS3), were identified through MEDLINE, Embase, and Web of Science. A random-effects meta-analysis was performed for the primary outcome (UPDRS3). Risk of bias was assessed using the Cochrane RoB tool, and certainty of evidence with GRADE. Meta-regression examined methodological, population, and intervention variables associated with effect size variation.ResultsForty-seven RCTs (56 intervention comparisons; 2,638 participants) were included. Thirty trials investigated non-invasive neuromodulation (mainly rTMS and tDCS) and 17 invasive approaches (DBS). Meta-analysis of 39 effect sizes (from studies during L-Dopa ON, near-term follow-up) showed a small but significant improvement with active MDBN (SMD = -0.18, p = 0.008; I 2 = 61%). Meta-regression showed larger effects in studies using intention-to-treat analysis and smaller effects when sham stimulation was used as a comparator.ConclusionMDBN is associated with modest yet significant motor improvements in PD. Effect size estimates are influenced by methodological characteristics, particularly analysis strategy and comparator selection. This is the first review in the field to calculate and incorporate separate effect sizes for each active intervention group in multi-arm trials, enabling more precise data inclusion.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.